Preclinical Development of a Bacteriophage Cocktail for Treating Multidrug Resistant <em>Pseudomonas aeruginosa</em> Infections

Preclinical Development of a Bacteriophage Cocktail for Treating Multidrug Resistant <em>Pseudomonas aeruginosa</em> Infections

A <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) airway infection is one of the predominant causes contributing to the high morbidity and mortality rates in cystic fibrosis (CF) patients. The emergence of antibiotic resistant <i>P. aeruginosa</i> strains has...

Full description

Bibliographic Details
Main Authors: Sophie Camens, Sha Liu, Karen Hon, George Spyro Bouras, Alkis James Psaltis, Peter-John Wormald, Sarah Vreugde
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Microorganisms
Subjects:
bacterial infection
bacteriophage
<i>Pseudomonas aeruginosa</i>
cystic fibrosis
multidrug resistance
phage therapy
Online Access:https://www.mdpi.com/2076-2607/9/9/2001

Internet

https://www.mdpi.com/2076-2607/9/9/2001

Similar Items